GGrantIndex
← Leaderboards

Sally Ann Frautschy

Va Greater Los Angeles Healthcare System

$9,944,052
Attributed
$10,628,909
Total exposure
13
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $701.8K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,628,909 · 9
VA$0 · 4

By mechanism

R01$6,896,622 · 5
P50$1,558,229 · 1
RC1$1,000,000 · 1
U01$827,558 · 1
R21$346,500 · 1
I01$0 · 4

Top collaborators

Most similar at Va Greater Los Angeles Healthcare System

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposInflammationPathogenesisS DiseaseTau ProteinsPathologyAmyloidResponseApolipoprotein EProteinsCognitivePlasmaBrainAgingSynergismNeurofibrillary TanglesPathway InteractionsTauopathiesAntioxidantsNerve DegenerationLaboratory MouseCurcuminAmyloid ProteinsNeurotoxicology

Grant awards (51)

Role of Complement Receptor Activation in a Mixed Dementia Model$0
I01 · FY2025 · VA · contact PI
Metabolic and Vascular Factors in tau pathogenesis$681,088
R01 · FY2024 · AG · contact PI
Role of Complement Receptor Activation in a Mixed Dementia Model$0
I01 · FY2024 · VA · contact PI
Metabolic and Vascular Factors in tau pathogenesis$677,968
R01 · FY2023 · AG · contact PI
Role of Complement Receptor Activation in a Mixed Dementia Model$0
I01 · FY2023 · VA · contact PI
Metabolic and Vascular Factors in tau pathogenesis$683,442
R01 · FY2022 · AG · contact PI
Neuroinflammation and Neurodegeneration in a Transgenic Alzheimer Rat with Vascular Disease$0
I01 · FY2022 · VA · contact PI
Metabolic and Vascular Factors in tau pathogenesis$677,968
R01 · FY2021 · AG · contact PI
Metabolic and Vascular Factors in tau pathogenesis$677,968
R01 · FY2020 · AG · contact PI
Neuroinflammation and Neurodegeneration in a Transgenic Alzheimer Rat with Vascular Disease$0
I01 · FY2020 · VA · contact PI
Neuroinflammation and Neurodegeneration in a Transgenic Alzheimer Rat with Vascular Disease$0
I01 · FY2019 · VA · contact PI
Neuroinflammation and Neurodegeneration in a Transgenic Alzheimer Rat with Vascular Disease$0
I01 · FY2018 · VA · contact PI
Modulation of tau pathogenesis by high dietary fat, gender and ApoE isoform$157,500
R21 · FY2017 · AG · contact PI
Neuroinflammation and Neurodegeneration in a Transgenic Alzheimer Rat with Vascular Disease$0
I01 · FY2017 · VA · contact PI
Modulation of tau pathogenesis by high dietary fat, gender and ApoE isoform$189,000
R21 · FY2016 · AG · contact PI
Polyphenolic Interventions for tau Pathogenesis in Alzheimers Models$0
I01 · FY2016 · VA · contact PI
Preclinical Pharmacogenomics and Synaptic Biomarkers for Alzheimer's Disease$369,715
R01 · FY2015 · AT
Polyphenolic Interventions for tau Pathogenesis in Alzheimers Models$0
I01 · FY2015 · VA · contact PI
Curcumin and Yoga Exercise Effects in Veterans at Risk for Alzheimer's Disease$0
I01 · FY2015 · VA · contact PI
Curcumin and Yoga Exercise Effects in Veterans at Risk for Alzheimer's Disease$0
I01 · FY2015 · VA · contact PI
Curcumin and Yoga Exercise Effects in Veterans at Risk for Alzheimer's Disease$0
I01 · FY2015 · VA · contact PI
Polyphenolic Interventions for tau Pathogenesis in Alzheimers Models$0
I01 · FY2014 · VA · contact PI
Polyphenolic Interventions for tau Pathogenesis in Alzheimers Models$0
I01 · FY2013 · VA · contact PI
Diet and Exercise (DE) Program for Alzheimer Prevention$500,000
RC1 · FY2010 · AG
Diet and Exercise (DE) Program for Alzheimer Prevention$500,000
RC1 · FY2009 · AG
Curcumin and Curcumin Derivatives for Alzheimer's$201,751
U01 · FY2009 · AG · contact PI
Human tau neurodegeneration in Alzheimer's$237,090
R01 · FY2008 · AG · contact PI
Curcumin and Curcumin Derivatives for Alzheimer's$201,751
U01 · FY2008 · AG · contact PI
Human tau neurodegeneration in Alzheimer's$241,929
R01 · FY2007 · AG · contact PI
Curcumin and Curcumin Derivatives for Alzheimer's$205,869
U01 · FY2007 · AG · contact PI
Human tau neurodegeneration in Alzheimer's$249,154
R01 · FY2006 · AG · contact PI
Curcumin and Curcumin Derivatives for Alzheimer's$218,187
U01 · FY2006 · AG · contact PI
Human tau neurodegeneration in Alzheimer's$255,150
R01 · FY2005 · AG
Human tau neurodegeneration in Alzheimer's$255,150
R01 · FY2004 · AG
ABETA ACCUMULATION AND TOXICITY IN AN ALZHEIMER$189,000
R01 · FY2004 · AG
CYTOKINE REGULATION OF BETA PROTEIN DEPOSITION$189,000
R01 · FY2004 · AG
ABETA ACCUMULATION AND TOXICITY IN AN ALZHEIMER$189,000
R01 · FY2003 · AG
CYTOKINE REGULATION OF BETA PROTEIN DEPOSITION$189,000
R01 · FY2003 · AG
A-BETA INFUSION INDUCED DEPOSITION, INFLAMMATION AND NEUROTOXICITY$228,564
P50 · FY2002 · AG
ABETA ACCUMULATION AND TOXICITY IN AN ALZHEIMER$189,000
R01 · FY2002 · AG
CYTOKINE REGULATION OF BETA PROTEIN DEPOSITION$189,000
R01 · FY2002 · AG
A-BETA INFUSION INDUCED DEPOSITION, INFLAMMATION AND NEUROTOXICITY$228,564
P50 · FY2001 · AG
A-BETA INFUSION INDUCED DEPOSITION, INFLAMMATION AND NEUROTOXICITY$228,404
P50 · FY2001 · AG
ABETA ACCUMULATION AND TOXICITY IN AN ALZHEIMER$189,000
R01 · FY2001 · AG
CYTOKINE REGULATION OF BETA PROTEIN DEPOSITION$189,000
R01 · FY2001 · AG
A-BETA INFUSION INDUCED DEPOSITION, INFLAMMATION AND NEUROTOXICITY$228,404
P50 · FY2000 · AG
A-BETA INFUSION INDUCED DEPOSITION, INFLAMMATION AND NEUROTOXICITY$228,404
P50 · FY2000 · AG
A-BETA INFUSION INDUCED DEPOSITION, INFLAMMATION AND NEUROTOXICITY$228,404
P50 · FY2000 · AG
ABETA ACCUMULATION AND TOXICITY IN AN ALZHEIMER$189,000
R01 · FY2000 · AG
CYTOKINE REGULATION OF BETA PROTEIN DEPOSITION$189,000
R01 · FY2000 · AG
A-BETA INFUSION INDUCED DEPOSITION, INFLAMMATION AND NEUROTOXICITY$187,485
P50 · FY2000 · AG